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AIMS AND SCOPE
Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes
clinical radiotherapy, combined modality treatment, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects
relevant to oncology, particularly in the ﬁeld of imaging, dosimetry and radiation therapy planning. Papers on more general aspects of interest to the radiation oncologist
including chemotherapy, surgery and immunology are also published.
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